AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glytylus-M2 Tablet ER

Prescription Icon
Prescription Required

Marketer

Capsutab Drugs Pvt Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glytylus-M2 Tablet ER

Diabetol Duo ER tablets are a dual-action antidiabetic medication, combining two agents to manage type 2 diabetes in adults. This formulation helps regulate blood glucose levels. Diabetol Duo ER should be ingested with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial; discontinuation without medical guidance can elevate blood sugar, potentially leading to kidney complications, vision loss, neuropathy, and limb amputation. Remember, it's a component of a comprehensive diabetes management plan that includes diet, exercise, and weight management as directed by your doctor. Lifestyle choices are key to diabetes control. The most frequent adverse effect is hypoglycemia (low blood sugar). Learn to identify its symptoms—sweating, dizziness, headache, and tremors—and how to treat it. Maintain regular mealtimes and carry a fast-acting glucose source like sugary snacks or juice. Alcohol consumption should be limited due to increased hypoglycemia risk. Other potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain is a possibility. This medication is contraindicated in individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Inform your physician of any history of heart disease before commencing treatment; it might be unsuitable. Pregnant or lactating women must consult their doctor prior to use. Regular blood glucose monitoring is essential, along with potential blood tests to assess blood cell counts and liver function.

Uses of Glytylus-M2 Tablet ER

Managing type 2 diabetes

Major Benefits of Glytylus-M2 Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for Glytylus-M2 Tablet ER. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Consume this medication with food.

Common Side effects of Glytylus-M2 Tablet ER:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glytylus-M2 Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for Glytylus-M2 Tablet ER. Ingest the tablet whole; avoid crushing, chewing, or breaking it. Administer this medication with food.

How Glytylus-M2 Tablet ER works:

Glytylus-M2 Extended-Release tablets combine glimepiride and metformin, two medications used to manage diabetes. Glimepiride, a sulfonylurea, enhances insulin secretion from the pancreas, thus reducing blood sugar levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and improving insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol use and Glytylus-M2 Tablet ER is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glytylus-M2 Extended-Release tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing this medication. Patient consultation with their doctor is advised.

Breast feedingBreast feedingUNSAFE

Extended-release Glytylus-M2 tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Exercise caution when prescribing Glytylus-M2 ER tablets to individuals with impaired renal function; dosage modification may be necessary. Consult a physician. Glytylus-M2 ER tablets are contraindicated in patients exhibiting severe kidney disease. Routine monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Exercise caution when prescribing Glytylus-M2 Tablet ER to individuals with hepatic impairment. Dosage modifications for Glytylus-M2 Tablet ER may be necessary; physician consultation is advised. A reduced initial dose of Glytylus-M2 Tablet ER is typically recommended for patients exhibiting mild to moderate liver dysfunction; its use is contraindicated in those with severe liver disease.

What if you forget to take Glytylus-M2 Tablet ER :

Should you forget a Glytylus-M2 Tablet ER dose, take it immediately. However, if your next dose is imminent, omit the missed one and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glytylus-M2 Tablet ER

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glytylus-M2 Tablet ER

Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medication; keep it out of reach of children, pets, and others.
Glytylus-M2 Tablet ER can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Glytylus-M2 Tablet ER and seek immediate medical attention.
Glytylus-M2 ER tablets combine glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 DM.
Glytylus-M2 Tablet ER may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged Glytylus-M2 Tablet ER use can lead to Vitamin B12 deficiency by impairing its absorption. This deficiency, if left unaddressed, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and balance difficulties (ataxia). To mitigate this risk, annual supplemental Vitamin B12 is recommended by some researchers.
Glytylus-M2 ER tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Combining Glytylus-M2 Tablet ER and alcohol is unsafe. This combination can lower blood sugar, causing hypoglycemia, and increase the risk of lactic acidosis.
Glytylus-M2 Tablet ER
178
MRP 217
18% off